Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | |
| Sales | 34,888 |
| Gross Profit | 34,888 |
| Operating Expenses | 52,073 |
| Operating Income | -17,185 |
| Interest Expense | 6,591 |
| Other Income | 88 |
| Pre-tax Income | -23,688 |
| Income Tax | -817 |
| Net Income Continuous | -22,871 |
| Net Income | $-22,871 |
| EPS Basic Total Ops | -0.94 |
| EPS Basic Continuous Ops | -0.94 |
| EPS Diluted Total Ops | -0.94 |
| EPS Diluted Continuous Ops | -0.94 |
| EPS Diluted Before Non-Recurring Items | -0.94 |
| EBITDA(a) | $-16,381 |